Client News
Filter by:
- Oct 14 2022 NeuBase Therapeutics Announces Strategic Restructuring Focused on Advancing Its Platform in Gene Editing
- Oct 10 2022 Profire Energy Announces Preliminary Third Quarter 2022 Revenue Range of $12.5 to $12.7 Million
- Oct 5 2022 Profire Energy, Inc. to Present and Host Investor Meetings at Dawson James Securities 7th Annual Small Cap Growth Conference on October 12th
- Oct 3 2022 Adamis Announces Review of Strategic Alternatives
- Oct 3 2022 NetCents Technology Provides Update on the Status of the Audit of Its 2020 Financial Statements
- Sep 22 2022 NeuBase to Participate at Chardan’s 6th Annual Genetic Medicines Conference
- Sep 21 2022 Adamis Provides Update on the Phase 2/3 Trial of Tempol in COVID-19 Positive High-Risk Subjects
- Sep 14 2022 NetCents Technology Provides Update on the Status of the Audit of Its 2020 and 2021 Financial Statements
- Sep 12 2022 Adamis Provides an Enrollment Update on the Phase 2/3 Study of Tempol in COVID-19 Positive High-Risk Subjects
- Aug 11 2022 NeuBase Therapeutics Reports Business Update and Financial Results for the Third Quarter of Fiscal Year 2022